Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination — MISTRAL

Ver todos los proyectos

Proyecto - Activo

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination — MISTRAL

1/2020 - 12/2024

Investigadores/as principales: Roger Paredes

flag_yellow_low_0.jpg

  • Entidades participantes: IrsiCaixa (coordinator), Universite d’Aix Marseille, Region Hovedstaden, Case Western Reserve University Corporation, Karolinska Institutet, Projecte dels Noms-Hispanosida Asociacion, Consorci Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Fundación Privada Instituto de Salud Global Barcelona (ISGlobal), Asphalion SL., AELIX Therapeutics, SL, Vedanta Biosciences, Inc.
  • Entidad financiadora: Horizon 2020 EU Framework Programme for Research and Innovation (Grant Agreement No. 847943)

Suscríbete a la newsletter

Back to Top
Irsi Caixa

Impulsado por:

Fundación 'La Caixa' Generalitat de Catalunya - Departament de Salut

 

HR Excellence in Research

Miembro de:

Cerca

Con la colaboración de: